CRISIL assigns \'BB-\' and \'P4+\' ratings to Kamdhenu Commercial (India)\'s ban
Chemical

CRISIL assigns \'BB-\' and \'P4+\' ratings to Kamdhenu Commercial (India)\'s ban

CRISIL has assigned its "˜BB-/Stable/P4+' ratings to the bank facilities of Kamdhenu Commercial (India) Pvt Ltd (KCPL). The ratings reflect KCPL's below-average financial risk profile, marked by a small net worth and weak debt protection metrics

  • By ICN Bureau | May 03, 2011

CRISIL has assigned its ?BB-/Stable/P4+? ratings to the bank facilities of Kamdhenu Commercial (India) Pvt Ltd (KCPL). The ratings reflect KCPL?s below-average financial risk profile, marked by a small net worth and weak debt protection metrics, exposure to intense competition in the edible oils industry, and short track record of operations. These rating weaknesses are partially offset by the extensive industry experience of KCPL?s promoters.

Outlook: Stable

CRISIL believes that KCPL will continue to benefit from the extensive industry experience of its promoters, over the medium term. The outlook may be revised to ?Positive? if the company?s financial risk profile improves substantially, most likely because of an improvement in capital structure and sustainable increase in revenues and profitability. Conversely, the outlook may be revised to ?Negative? if KCPL undertakes a larger-than-expected, debt-funded capital expenditure programme, or reports a decline in its margins and revenues.

 

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.